1. Enhanced Antitumor Activity with Combining Effect of mTOR Inhibition and Microtubule Stabilization in Hepatocellular Carcinoma
   Qian Zhou et al, 2013, International Journal of Hepatology CrossRef
2. Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancer
   Kazuya Maeda et al, 2020, Journal of Ovarian Research CrossRef
3. Construction of a combined random forest and artificial neural network diagnosis model to screening potential biomarker for hepatoblastoma
   Shaowen Liu et al, 2022, Pediatric Surgery International CrossRef
4. Glyceraldehyde-3-Phosphate Dehydrogenase: A Promising Target for Molecular Therapy in Hepatocellular Carcinoma
   Shanmugasundaram Ganapathy-Kanniappan et al, 2012, Oncotarget CrossRef
5. Hepatocellular carcinoma: Understanding molecular mechanisms for defining potential clinical modalities
   Abhiram Natu et al, 2021, World Journal of Hepatology CrossRef
6. Case report: Remarkable response to sintilimab, lenvatinib, and nab-paclitaxel in postoperative metastatic chemotherapy-resistant combined hepatocellular-cholangiocarcinoma
   Nan Zhou et al, 2023, Frontiers in Pharmacology CrossRef
7. MET-dependent cancer invasion may be preprogrammed by early alterations of p53-regulated feedforward loop and triggered by stromal cell-derived HGF
   Chang-Il Hwang et al, 2011, Cell Cycle CrossRef
8. microRNA regulation of cell viability and drug sensitivity in lung cancer
   Liqin Du et al, 2012, Expert Opinion on Biological Therapy CrossRef
9. Direct Computer Mapping Based Modeling of a Multiscale Process Involving p53/miR-34a Signaling
   Béla Csukás et al, 2013, Systems Biology CrossRef
10. Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion
    P A J Muller et al, 2013, Oncogene CrossRef